CORRELL DONALD L

SEC source: 0001199794-26-000002 · wk-form4_1767821879.xml · derivative · entry 2

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,030.879

Underlying: Common Stock · 870.2 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of NJR's Common Stock plus dividend equivalents.

F4 · derivative.exercise_date: The restricted stock unit award represents director fees that were deferred pursuant to the NJR Directors' Deferred Compensation Plan to be paid in NJR Common Stock in five installments beginning in January 2026.

F4 · derivative.expiration_date: The restricted stock unit award represents director fees that were deferred pursuant to the NJR Directors' Deferred Compensation Plan to be paid in NJR Common Stock in five installments beginning in January 2026.

SEC source: 0001199794-26-000002 · wk-form4_1767821879.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,565.876

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the distribution of restricted stock units, including 137 shares for accrued dividends, for the 2021 restricted stock unit vesting that was deferred pursuant to the New Jersey Resources Corporation ("NJR") Directors' Deferred Compensation Plan. Each share of restricted stock units and dividend equivalents is the economic equivalent of one share of NJR Common Stock.

F2 · balance_after: Total adjusted for .078 accrued dividends under the NJR Dividend and Reinvestment Plan.

SEC source: 0000356309-25-000019 · wk-form4_1737663219.xml · derivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,975.727

Underlying: Common Stock · 3,975.727 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents the annual Restricted Stock Unit ("RSU") retainer pursuant to the Non-Employee Director Compensation Plan, as amended. Each RSU represents a contingent right to receive one share of New Jersey Resources Corporation ("NJR") common stock plus dividend equivalents.

F2 · derivative.exercise_date: The RSU award will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date of the next NJR Annual Meeting of Shareowners.

F2 · derivative.expiration_date: The RSU award will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date of the next NJR Annual Meeting of Shareowners.

SEC source: 0001127602-24-013005 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,938

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2024, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $80.73. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0000356309-24-000025 · wk-form4_1706300929.xml · derivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,317.582

Underlying: Common Stock · 4,317.582 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents the annual Restricted Stock Unit ("RSU") retainer pursuant to the Non-Employee Director Compensation Plan, as amended. Each RSU represents a contingent right to receive one share of New Jersey Resources Corporation ("NJR") common stock plus dividend equivalents.

F2 · derivative.exercise_date: The RSU award will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date of the next NJR Annual Meeting of Shareowners.

F2 · derivative.expiration_date: The RSU award will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date of the next NJR Annual Meeting of Shareowners.

SEC source: 0001127602-24-001407 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,754

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 16, 2024, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $71.45. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-23-026011 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,546

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 16, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $63.77. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-23-020901 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,315

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 17, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $67.54. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-23-014807 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,097

F1 · shares: Annual grant of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-23-013200 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,712

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 17, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $61.39. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0000356309-23-000024 · wf-form4_167485395116900.xml · derivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,529.649

Underlying: Common Stock · 3,529.649 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents the annual RSU retainer pursuant to the Non-Employee Director Compensation Plan, as amended. Each RSU represents a contingent right to receive one share of New Jersey Resources Corporation ("NJR") common stock plus dividend equivalents.

F2 · derivative.exercise_date: The RSU award will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date of the next NJR Annual Meeting of Shareowners.

F2 · derivative.expiration_date: The RSU award will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date of the next NJR Annual Meeting of Shareowners.

SEC source: 0001127602-23-001753 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,479

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 17, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $61.16. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-22-024112 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,246

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 17, 2022, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $48.81. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-22-019593 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,983

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 20, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $49.19. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-22-013825 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,447

F1 · shares: Annual grant of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-22-012237 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,221

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $71.41. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0000356309-22-000039 · wf-form4_164338743117163.xml · derivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,221.028

Underlying: Common Stock · 4,221.028 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of New Jersey Resources Corporation ("NJR") common stock plus dividend equivalents.

F2 · shares: Reporting person has elected to defer issuance of shares of this RSU award upon vesting pursuant to the NJR Directors' Deferred Compensation Plan. Vested shares and dividend equivalents will be paid out in five (5) annual installments beginning on the first day of the second month of the calendar quarter in which the reporting person ceases to be a Director.

F3 · derivative.exercise_date: The RSU award will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date of the next NJR Annual Meeting of Shareowners.

F3 · derivative.expiration_date: The RSU award will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date of the next NJR Annual Meeting of Shareowners.

SEC source: 0001127602-22-001727 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,923

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $61.63. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-21-027250 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,580

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $67.62. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-21-022094 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,269

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $79.89. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-21-015982 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,006

F1 · shares: Award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-21-013951 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,249

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $82.66. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0000356309-21-000026 · wf-form4_161134707735338.xml · derivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,199.328

Underlying: Common Stock · 4,199.328 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of New Jersey Resources ("NJR") common stock plus dividend equivalents.

F2 · shares: Reporting person has elected to defer issuance of shares of this RSU award upon vesting pursuant to the NJR Directors' Deferred Compensation Plan. Vested shares and dividend equivalents will be paid out in five annual installments beginning in January 2026, or, if earlier, the first day of the second month of the calendar quarter in which the reporting person ceases to be a Director.

F3 · derivative.exercise_date: The RSU award will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date of the next NJR Annual Meeting of Shareowners.

F3 · derivative.expiration_date: The RSU award will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date of the next NJR Annual Meeting of Shareowners.

SEC source: 0001127602-21-002084 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,002

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $83.42. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-20-027242 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,758

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $68.11. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-20-021826 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,460

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $65.21. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-20-015799 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,151

F1 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-20-013953 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,847

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $69.76. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0000356309-20-000037 · wf-form4_158462365850118.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,558.098

F1 · balance_after: Total includes dividends of .232 shares of New Jersey Resources Corporation (NJR) Common Stock accrued through the NJR Dividend Reinvestment Plan.

SEC source: 0001127602-20-010806 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,568

SEC source: 0000356309-20-000006 · wf-form4_157990419665102.xml · derivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,449.069

Underlying: Common Stock · 3,449.069 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of NJR's common stock plus accrued dividend equivalents.

F2 · shares: Reporting person has elected to defer issuance of shares of this RSU Award upon vesting pursuant to the NJR Directors Deferred Compensation Plan.

F3 · derivative.exercise_date: The RSU award will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date of the next NJR Annual Meeting of Shareowners.

F3 · derivative.expiration_date: The RSU award will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date of the next NJR Annual Meeting of Shareowners.

SEC source: 0001127602-20-001988 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,568

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $77.50. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-19-030668 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,318

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2019, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $64.71. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-19-024789 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,020

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $64.39. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-19-017540 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,732

F1 · shares: Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-19-016094 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,405

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $61.37. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-19-002120 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,114

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0000356309-19-000004 · wf-form4_154663916567282.xml · derivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,491.689

Underlying: Common Stock · 2,472 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Phantom Stock Unit is the economic equivalent of one (1) share of New Jersey Resources Corporation (NJR) Common Stock.

F2 · derivative.exercise_date: The Phantom Stock Units represent director fees that are deferred pursuant to NJR's Directors Deferred Compensation Plan and are to be paid in 5 equal annual payments in NJR Common Stock when Mr. Correll ceases to be a Director.

F2 · derivative.expiration_date: The Phantom Stock Units represent director fees that are deferred pursuant to NJR's Directors Deferred Compensation Plan and are to be paid in 5 equal annual payments in NJR Common Stock when Mr. Correll ceases to be a Director.

F3 · balance_after: The total includes an accrual of 252.064 shares of NJR Common Stock through the NJR Dividend Reinvestment Plan.

SEC source: 0001127602-18-030490 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,845

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2018, Encompass Health paid a dividend on its common stock of $0.27 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-18-023476 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,607

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-18-016515 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,370

F1 · shares: Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-18-014894 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,984

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-18-002076 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,710

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0000356309-18-000024 · wf-form4_151502689961968.xml · derivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,767.625

Underlying: Common Stock · 2,635 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Phantom Stock Unit is the economic equivalent of one (1) share of New Jersey Resources Corporation (NJR) Common Stock.

F2 · derivative.exercise_date: The Phantom Stock Units represent director fees that are deferred pursuant to NJR's Directors Deferred Compensation Plan and are to be paid in five equal annual payments in NJR Common stock when Mr. Correll ceases to be a Director.

F2 · derivative.expiration_date: The Phantom Stock Units represent director fees that are deferred pursuant to NJR's Directors Deferred Compensation Plan and are to be paid in five equal annual payments in NJR Common stock when Mr. Correll ceases to be a Director.

F3 · balance_after: Total includes an accrual of 527.715 shares of NJR Common Stock through the NJR Dividend Reinvestment Plan (DRP).

SEC source: 0001127602-17-029991 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,407

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 16, 2017, HealthSouth paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-17-023857 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,063

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-17-017055 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,741

F1 · shares: Award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-17-015054 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,675

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0000356309-17-000032 · wf-form4_148607163221419.xml · derivative · entry 2

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,604.91

Underlying: Common Stock · 2,825 shares

Expires 2017-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Phantom Stock Unit is the economic equivalent of one (1) share of New Jersey Resources Corporation (NJR) Common Stock.

F1 · price: Each Phantom Stock Unit is the economic equivalent of one (1) share of New Jersey Resources Corporation (NJR) Common Stock.

F3 · balance_after: Total includes 109.317 shares of accrued dividends.

SEC source: 0000356309-17-000032 · wf-form4_148607163221419.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,557.866

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Phantom Stock Unit is the economic equivalent of one (1) share of New Jersey Resources Corporation (NJR) Common Stock.

F2 · balance_after: Total includes an accrual of 2.692 shares of NJR Common Stock through the NJR Dividend Reinvestment Plan (DRP).